Ready to Ship!

Dapagliflozin Tablets (Jiudian) 10mg – Factory low price wholesale

2 Reviews

-54%
2 Reviews
✖ CURRENTLY OUT OF STOCK
Your Perfect Ride Awaits
  • Free Home delivery available
  • Friendly customer support
  • Best pricing for you
  • COD available
  • Easy EMI
Guaranteed Safe Checkout

Request a Call Back
DescriptionDapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, designed to limit glucose reabsorption in the kidney, thereby promoting urinary glucose excretion. It has become a key compound in research on type 2 diabetes, insulin resistance, and renal glucose transport.The Jiudian formulation offers consistent 10mg dosing, suitable for in vitro and in vivo studies focused on glycemic control, energy homeostasis, and cardiometabolic pathways.?? This product is intended only for laboratory research. Not for human or veterinary administration. Contents hide 1 Product Specifications 2 Mechanism & Research Applications 3 Observed Effects in Research Models 4 Safety & Handling 5 Research Use Disclaimer Product SpecificationsParameterDetailsProduct NameDapagliflozin Tablets (Jiudian)Generic NameDapagliflozinCAS Number461432-26-8Molecular FormulaC21H25ClO6Molecular Weight408.87 g/molDosage FormTabletStrength10mg per tabletQuantity21 tablets per box (3 blisters of 7 tablets)Approval NumberH20249826 (China NMPA)Product Code86904942001166ManufacturerHunan Jiudian Pharmaceutical Co., Ltd.Storage ConditionsStore below 25°C in a dry, sealed containerIntended UseLaboratory research onlyMechanism & Research ApplicationsDapagliflozin selectively inhibits SGLT2 in the proximal renal tubules, reducing glucose reabsorption and increasing urinary glucose excretion. In laboratory environments, this mode of action supports the following research fields:Experimental models of type 2 diabetes mellitus (T2DM)Studies on renal glucose handling and reabsorption mechanismsInsulin sensitivity and glycemic control researchComparative pharmacology of SGLT2 inhibitorsPreclinical evaluation of cardio-renal protective strategiesObserved Effects in Research ModelsIn research settings, dapagliflozin has demonstrated:Significant reduction in postprandial and fasting glucose levelsWeight reduction and caloric loss through glucosuriaImproved insulin sensitivity in metabolic modelsRenoprotective markers under hyperglycemic conditionsSafety & HandlingIntended Use: Research only – Not for clinical, diagnostic, or veterinary applicationHandling Precautions: Wear gloves, lab coat, and safety gogglesStorage: Keep sealed and store in a dry, cool environmentDisposal: Comply with local and institutional chemical disposal protocolsResearch Use DisclaimerThis product is strictly intended for laboratory research use only. It is not approved for human or veterinary consumption. Use in clinical settings is prohibited. Handle according to institutional biosafety standards.

Specifications

×

Submit Your Details

Thank You!

We've received your details. We will notify you once stock is back.

Let us help you find the perfect wheelchair for your needs!

Share your name and email for a quick callback.

Model Ryder 1 Pro F16
 Frame Style Foldable
 Frame Material  MS
 Out to Out Width In open   Position  24"
 Seat Width 18"
 Total Width in Closing   Position 10"
 Rear Wheel Size 16"
 Front Wheel Size 6"
 Seat to Floor Height In 19"
 Seat Depth 15"
 Back height 14"
 Total Height 33"
 Total Length 32"
Armrest Height from seat 8"
 Max user Weight Capacity 100 Kg
 Net Weight 10.2 KG
Gross Weight 11.5 KG
 Upholstery Nylon
 Armrest PVC Plastic
 Footrest PVC Plastic
 Wheel Quality Mag 
 Rear Wheel Lock Yes
 Hand Brakes Yes
Foldable Backrest N/A
 Wheel Type Solid